Aidapak Recalls Perphenazine Tablets Due to Potential Label Mixup
Aidapak Services is recalling Perphenazine 8 mg tablets that may have been mislabeled as Nifedipine 10 mg capsules.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a labeling error that could result in temporary or medically reversible health consequences. The hazard is a label mixup between two different drugs, which is a significant but potentially reversible risk compared to contamination or structural defects.
Plain-English summary
Aidapak Services, LLC is recalling Perphenazine, Tablet, 8 mg, NDC 00630506221. The recall is due to a labeling error where the product may have been mislabeled as Nifedipine, Capsule, 10 mg, NDC 59762100401.
The affected Perphenazine tablets have the pedigree AD54605_1 and an expiration date of 4/30/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Patients and healthcare providers should check their medication labels. If the medication is identified as Perphenazine 8 mg with the specified pedigree, it should be returned to the pharmacy or healthcare provider for replacement or disposal.
The recalled product
- Product
- PERPHENAZINE, Tablet, 8 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00630506221.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- PERPHENAZINE
- Tablet
- 8 mg has the following codes: Pedigree: AD54605_1
- EXP: 4/30/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateNifedipine Capsules Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Nifedipine Capsules Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- HighAidapak Recalls Mirtazapine Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- HighAripiprazole Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Tizanidine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModeratePrednisone Tablets Recalled for Potential Label Mixup with Aspirin
FDA (Drugs) · 2014-01-22